RIQAS is the world’s largest External Quality Assessment scheme with more than 50,000 laboratory participants spanning over 139 countries
RIQAS Pilot Programmes
RIQAS Haematology 5-Part Differentials & Reticulocytes – Pilot Study
This new Haematology pilot study will be suitable for use across multiple analytical systems however, manual method will not be assessed. Consisting of 3 samples covering multiple concentrations, this pilot is open for current and potential participants. The EQA material will be provided in 3 primary sample tubes with a volume of 2ml (3 x 2ml)
Key Benefits
- Liquid ready-to-use sample material
- Submit results and view reports online via RIQAS.net
- Human-based, preserved, whole blood samples – no latex or artificial particles used in production, stabilised mammalian cells only
- All samples should be analysed and results submitted together
| RIQAS Haematology 5-Part Differentials & Reticulocytes – Pilot Study Analytes | |||
|---|---|---|---|
| Haemoglobin | MPV | RDW-CV | WBC Eos |
| HCT | PCT | RDW-SD | WBC Lym |
| MCH | PDW | Reticulocytes | WBC Mon |
| MCHC | PLT | WBC | WBC Neu |
| MCV | RBC | WBC Bas | |
| Cat. Number | Kit Size | Parameters | |
|---|---|---|---|
| RQ9192 | 3 x 2ml | 19 |
RIQAS Neonatal Bilirubin – Pilot Study
Further expansion of our RIQAS portfolio via the introduction of this new pilot study. Designed to assess the performance of total and direct bilirubin assays with levels tailored specifically to neonatal bilirubin testing.
Direct Bilirubin (2.8 – 278 umol/l) | Total Bilirubin (4.8 – 638 umol/l)
Key Benefits
- Lyophilised samples for enhanced stability
- Submit results and view reports online via RIQAS.net
- Human based serum matrix
- All samples should be analysed and results submitted together
| RIQAS Neonatal Bilirubin – Pilot Study Analytes | |
|---|---|
| Direct Bilirubin | Total Bilirubin |
| Cat. Number | Kit Size | Parameters | |
|---|---|---|---|
| RQ9191 | 2 x 3ml | 2 |
RIQAS Cytokines – Pilot Study
This is a comprehensive EQA programme suitable for monitoring the performance of 12 different Cytokines including Interleukin 6 (IL-6), Epidermal Growth Factor (EGF) and more.
Key Benefits
- Lyophilised samples for enhanced stability
- Submit results and view reports online via RIQAS.net
- Samples are manufactured to the highest quality ensuring the matrix reacts in the same manner as patients sample.
- All samples should be analysed and results submitted together
| RIQAS Cytokines – Pilot Study Analytes | ||
|---|---|---|
| Epidermal Growth Factor (EGF) | Interleukin-2 (IL-2) | Interleukin-10 (IL-10) |
| Interferon gamma (INF-Y) | Interleukin-4 (IL-4) | Monocyte Chemoattractant Protein-1 (MCP-1) |
| Interleukin-1 alpha (IL-1α) | Interleukin-6 (IL-6) | Tumour Necrosis Factor alpha (TNF-α) |
| Interleukin-1 beta (IL-1β) | Interleukin-8 (IL-8) | Vascular Endothelial Growth Factor (VEGF) |
| Cat. Number | Kit Size | Parameters | |
|---|---|---|---|
| RQ9195 | 3 x 1ml | 12 |
